News APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF) Staff September 11, 2023 Iframe sync Post navigation Previous: Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of DirectorsNext: Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse More Stories News Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan Staff December 22, 2025 News FlyteHealth to Expand Direct Access to Obesity Management Medication for Employers Staff December 22, 2025 Healthcare Mental Health News 10 Days, 10 Ways to Spend FSA (Flexible Spending Account) Funds Before the December 31 Use-It-or-Lose-It Deadline, from FSA Store® Staff December 22, 2025
